BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10390064)

  • 1. Cervical intraepithelial neoplasia grade III (CIN III) and invasive cervical carcinoma: the yawning gap revisited and the treatment of risk.
    Herbert A; Smith JA
    Cytopathology; 1999 Jun; 10(3):161-70. PubMed ID: 10390064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.
    Wang J; Andrae B; Sundström K; Ström P; Ploner A; Elfström KM; Arnheim-Dahlström L; Dillner J; Sparén P
    BMJ; 2016 Feb; 352():i276. PubMed ID: 26869597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based cervical screening with a 5-year interval in The Netherlands. Stabilization of the incidence of squamous cell carcinoma and its precursor lesions in the screened population.
    Siemens FC; Boon ME; Kuypers JC; Kok LP
    Acta Cytol; 2004; 48(3):348-54. PubMed ID: 15192950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities.
    Castle PE; Gravitt PE; Wentzensen N; Schiffman M
    Am J Clin Pathol; 2012 Aug; 138(2):241-6. PubMed ID: 22904136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
    Gram IT; Macaluso M; Stalsberg H
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
    Macgregor JE; Campbell MK; Mann EM; Swanson KY
    BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme.
    Herbert A; Anshu ; Culora G; Dunsmore H; Gupta SS; Holdsworth G; Kubba AA; McLean E; Sim J; Raju KS
    BJOG; 2010 May; 117(6):736-45. PubMed ID: 20184570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of high-grade cervical intraepithelial neoplasia among young women with abnormal screening cytology.
    Massad SL; Markwell S; Cejtin HE; Collins Y
    J Low Genit Tract Dis; 2005 Oct; 9(4):225-9. PubMed ID: 16205193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion.
    Vale DB; Westin MC; Zeferino LC
    Cancer Cytopathol; 2013 Oct; 121(10):576-81. PubMed ID: 23765869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of squamous atypia (borderline nuclear abnormalities): repeat cytology or colposcopy?
    Tay SK; Jenkins D; Singer A
    Aust N Z J Obstet Gynaecol; 1987 May; 27(2):140-1. PubMed ID: 2823785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
    Bratti MC; Rodríguez AC; Schiffman M; Hildesheim A; Morales J; Alfaro M; Guillén D; Hutchinson M; Sherman ME; Eklund C; Schussler J; Buckland J; Morera LA; Cárdenas F; Barrantes M; Pérez E; Cox TJ; Burk RD; Herrero R
    Rev Panam Salud Publica; 2004 Feb; 15(2):75-89. PubMed ID: 15030652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of cervical intraepithelial neoplasia and invasive carcinoma based on cytological screening in the region of Campinas, São Paulo, Brazil.
    d'Ottaviano-Morelli MG; Zeferino L; Cecatti JG; Terrabuio DR; Martinez EZ
    Cad Saude Publica; 2004; 20(1):153-9. PubMed ID: 15029316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of cervical intraepithelial neoplasia in a population of pregnant women with an abnormal cytology.
    Pruski D; Malkowska-Walczak B; Paluszkiewicz A; Kędzia W
    Ginekol Pol; 2017; 88(1):20-23. PubMed ID: 28157250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological study on the prevalence of cervical intraepithelial neoplasia among married women aged 25-54 years in Beijing between 2007-2008].
    Zhang WY; Wu MH; Zhang SW; Zhou BL; Li CD; Wang JD; Zhu L; Pan J
    Zhonghua Fu Chan Ke Za Zhi; 2010 Mar; 45(3):161-4. PubMed ID: 20450749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
    Nygård JF; Nygård M; Skare GB; Thoresen SØ
    Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Descriptive study of cervical intraepithelial neoplasia grade III (CIN III) cases in the area of the hospital of Barbastro].
    Oncins R; Fuente C; Nájar M
    Aten Primaria; 2001 Oct; 28(7):457-62. PubMed ID: 11718640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.